Cargando…
Update on bazedoxifene: A novel selective estrogen receptor modulator
In the elderly population, osteoporosis is a significant clinical problem leading to disability and even death. Many patients remain untreated, despite effective therapies, because of patients’ unwillingness to take current therapies or inability to tolerate the therapies. For this reason, ongoing r...
Autor principal: | Biskobing, Diane M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685267/ https://www.ncbi.nlm.nih.gov/pubmed/18044180 |
Ejemplares similares
-
Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
por: Thilakasiri, Pathum, et al.
Publicado: (2019) -
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017) -
Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats
por: Maekawa, Hidetsugu, et al.
Publicado: (2017) -
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012) -
Bazedoxifene, a Selective Estrogen Receptor Modulator, Promotes Functional Recovery in a Spinal Cord Injury Rat Model
por: Kim, Yiyoung, et al.
Publicado: (2021)